The 2025 YouGov survey data from more than 31,000 US adults show significant support for recreational cannabis legalization, medical use, and federal reclassification.
|Webcasts|April 27, 2021
Cannabis and Chronic Pain
Author(s)Hemp Fusion
*Live: Tuesday, April 27, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST* Public support for cannabis legalization is rising with 2/3rd of Americans supporting it. It is speculated that public acceptance of cannabis is largely due to the application of cannabis as a medicine. Chronic pain affects approximately 50 million Americans cannabis has shown to be an effective treatment option. Join us as we discuss the science and practical applications of cannabis for chronic pain. *On Demand Until April 27, 2022*
Register Free:
Event Overview:
According the Centers for Disease Control, chronic pain affects 20% of U.S adults and it is the top reason for adults to seek medical care. It is not uncommon for chronic pain to lead to other symptoms such as depression, anxiety, insomnia, and fatigue. The current accepted pharmacological pain management options to manage chronic pain include opioids, muscle relaxers, NSAID’s, antidepressants and anticonvulsants.
In 2017, the National Academy of Sciences, Engineering and Medicine released its report on Health Effects of cannabis and cannabinoids. In their report, they found conclusive evidence that cannabis and cannabinoids are effective in the treatment of chronic pain. This event will review the science around using cannabis for chronic pain and effective strategies to manage chronic pain with cannabis with a presentation from Eloise Theisen followed by a round-table discussion with several chronic pain patients using medical cannabis.
Key Learning Objectives:
- Identify effective cannabinoids for use in chronic pain
- Discuss current evidence to support the use of cannabinoids for chronic pain
- Discuss routes of administration that may be beneficial in the use of chronic pain
Speaker: Eloise Theisen, MSN, RN, AGPCNP-BC, Adult Geriatric Nurse Practitioner, Radicle Health/Leaf411
Time and Date: Tuesday, April 27, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Sponsored by: Hemp Fusion
Register Free:
Related to this article
Curaleaf is opening a new cannabis dispensary called Curaleaf Millcreek in Erie, Pennsylvania.
Learn how third-party audits enhance compliance in the cannabis industry, ensuring readiness for evolving regulations and fostering consumer trust.
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
A lack of standards for cannabis vape devices puts consumers at risk, but several organizations are committed to the research, collaboration, and solutions needed to promote safety and quality in the industry.
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!